Sound wave surgery zaps kidney tumors in first human test
NCT ID NCT05432232
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new device that uses focused ultrasound (histotripsy) to break apart solid kidney tumors without making any cuts. Twenty adults with small, non-spreading kidney tumors were treated. The main goals were to see if the device could fully cover the tumor and if there were any major complications within 30 days.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Leeds Teaching Hospitals NHS Trust
Leeds, LS9 7TF, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new biologic boost standard brain cancer therapy?
- Can a new PET tracer spot thyroid cancer recurrence more clearly?
- Can AI outthink cancer experts? a landmark trial pits five AIs against tumor boards
- Can a pill that starves tumors of oxygen help fight advanced cancer?
- New imaging agent could sharpen cancer detection
- Could an ALS drug clear the fog of chemo brain?